NADPH Oxidase: A Potential Therapeutic Target to Reduce Primary Sclerosis Cholangitis Following Liver Transplantation

The molecular mechanisms and causes of primary sclerosis cholangitis (PSC) post-liver transplantation are still unclear. PSC is a progressive cholestatic hepatobiliary disease that happens in about 25% of patients post-liver transplantation and requires re-- transplantation. Nicotinamide adenine din...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Current medicinal chemistry Ročník 32; číslo 32; s. 8598
Hlavní autori: Aliakbarian, Mohsen, Ashrafzadeh, Kiarash, Ferns, Gordon A, Hadian, Reyhaneh, Khodashahi, Rozita, Arjmand, Mohammad-Hassan
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United Arab Emirates 01.01.2025
Predmet:
Animals
Cholangitis, Sclerosing - drug therapy
Cholangitis, Sclerosing - enzymology
Cholangitis, Sclerosing - etiology
Cholangitis, Sclerosing - metabolism
Cholangitis, Sclerosing - prevention & control
Humans
Liver Transplantation - adverse effects
NADPH Oxidases - antagonists & inhibitors
NADPH Oxidases - metabolism
Reactive Oxygen Species - metabolism
fibrosis
primary sclerosis cholangitis
ischemic reperfusion injury
NADPH oxidase
liver transplantation
ISSN:1875-533X, 1875-533X
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:The molecular mechanisms and causes of primary sclerosis cholangitis (PSC) post-liver transplantation are still unclear. PSC is a progressive cholestatic hepatobiliary disease that happens in about 25% of patients post-liver transplantation and requires re-- transplantation. Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase or Nox) is a family of transmembrane proteins whose main function is producing reactive oxygen species (ROS). ROS generation as a result of NADPH oxidase activity of Kupffer cells and polymorphonuclear leukocytes has been implicated in the pathogenesis of ischemia-reperfusion injuries after liver transplantation, and is related to intraand/ or extrahepatic non-anastomotic biliary stenosis or PSC. In addition, Nox-derived ROS upregulates several molecular pathways to induce hepatocyte apoptosis and hepatic stellate cell (HSC) activation to promote hepatobiliary fibrogenesis. Understanding the multiple molecular aspects of Nox in the development of PSC post-transplantation may help identify new drugs to prevent this disorder.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1875-533X
1875-533X
DOI:10.2174/0109298673356252250213105931